TECON, a listed company based in the Xinjiang Production and Construction Corps in Northwest China’s Xinjiang Uygur autonomous region, broke ground on an R&D headquarters and smart animal vaccine manufacturing base in SIP on Nov 8.
The company, engaged in developing biological products for animals, plans to invest RMB 1 billion to build a comprehensive facility for business operation, R&D, marketing and vaccine production in SIP, and will invest about RMB 100 million for R&D each year after it comes into operation.
The new facility is expected to produce more than 10 billion milliliters of vaccines each year, with sales exceeding RMB 2 billion.
November 8, 2021
